Oleg V. Evgenov
- The stimulator of soluble guanylate cyclase riociguat protects against bleomycin-induced pulmonary fibrosis in miceBy Oleg V. Evgenov, Johannes-Peter Stasch, Mari Mino-Kenudson, Eugene J. Mark, Emmanuel S. Buys, Lin Zou, Ming Zhang, Michael J. Raher, Yan Li, Yan Feng, Rosemary C. Jones and Wei ChaoOleg V. Evgenov1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesJohannes-Peter Stasch2Institute of Pharmacy, Martin Luther University, Halle, GermanyMari Mino-Kenudson3Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesEugene J. Mark3Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesEmmanuel S. Buys1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesLin Zou1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesMing Zhang1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesMichael J. Raher1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesYan Li1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesYan Feng1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesRosemary C. Jones1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United StatesWei Chao1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
- Soluble guanylate cyclase stimulator riociguat prevents fibrotic tissue remodeling and improves survival in salt-sensitive Dahl ratsBy Johannes-Peter Stasch, Sandra Geschka, Bettina Lawrenz, Yuliya Sharkovska, Berthold Hocher, Oleg V. Evgenov and Axel KretschmerJohannes-Peter Stasch1Cardiology Research, Bayer HealthCare, Wuppertal, GermanySandra Geschka1Cardiology Research, Bayer HealthCare, Wuppertal, GermanyBettina Lawrenz2Pathology, Bayer HealthCare, Wuppertal, GermanyYuliya Sharkovska3Institute of Pharmacology and Toxicology, Charité, Berlin, GermanyBerthold Hocher3Institute of Pharmacology and Toxicology, Charité, Berlin, GermanyOleg V. Evgenov4Department of Anesthesia and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston, United StatesAxel Kretschmer5Biomarker, Bayer HealthCare, Wuppertal, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.